Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective.
Saved in:
| Title: | Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. |
|---|---|
| Authors: | Sampson MR; Division of Clinical Pharmacology 4, Office of Clinical Pharmacology, Office of Translational Sciences Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Troy SB, Belew Y, Arya V, Struble KA |
| Source: | Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2020 Jan; Vol. 15 (1), pp. 61-65. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101264945 Publication Model: Print Cited Medium: Internet ISSN: 1746-6318 (Electronic) Linking ISSN: 1746630X NLM ISO Abbreviation: Curr Opin HIV AIDS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31483323 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sampson+MR%22">Sampson MR</searchLink>; Division of Clinical Pharmacology 4, Office of Clinical Pharmacology, Office of Translational Sciences Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Troy+SB%22">Troy SB</searchLink><br /><searchLink fieldCode="AU" term="%22Belew+Y%22">Belew Y</searchLink><br /><searchLink fieldCode="AU" term="%22Arya+V%22">Arya V</searchLink><br /><searchLink fieldCode="AU" term="%22Struble+KA%22">Struble KA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101264945%22">Current opinion in HIV and AIDS</searchLink> [Curr Opin HIV AIDS] 2020 Jan; Vol. 15 (1), pp. 61-65. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101264945 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1746-6318 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221746630X%22">1746630X </searchLink><i>NLM ISO Abbreviation: </i>Curr Opin HIV AIDS <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31483323 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/COH.0000000000000587 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 61 Titles: – TitleFull: Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sampson MR – PersonEntity: Name: NameFull: Troy SB – PersonEntity: Name: NameFull: Belew Y – PersonEntity: Name: NameFull: Arya V – PersonEntity: Name: NameFull: Struble KA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2020 Jan Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1746-6318 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Current opinion in HIV and AIDS Type: main |
| ResultId | 1 |
